Publication:
Capecitabine-induced cardiotoxicity mimicking myocardial infarction

dc.contributor.buuauthorŞentürk, Tunay
dc.contributor.buuauthorKanat, Özkan
dc.contributor.buuauthorEvrensel, Türkkan
dc.contributor.buuauthorAydınlar, Ali
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentKardiyoloji Ana Bilim Dalı
dc.contributor.departmentTıbbi Onkoloji Ana Bilim Dalı
dc.contributor.orcid0000-0002-8974-8837
dc.contributor.researcheridC-1517-2017
dc.contributor.researcheridAAI-6632-2021
dc.contributor.scopusid8342098300
dc.contributor.scopusid55881548500
dc.contributor.scopusid6603942124
dc.contributor.scopusid6603131517
dc.date.accessioned2021-12-09T08:01:59Z
dc.date.available2021-12-09T08:01:59Z
dc.date.issued2009-08
dc.description.abstractCapecitabine, a fluoropyrimidine derivative, is an orally administered drug that delivers 5-fluorouracil (5-FU) selectively to the tumour. The drug has demonstrated activity in metastatic colorectal cancer. We describe a male patient receiving capecitabine therapy with typical chest pain and electrocardiographic changes consistent with ST-segment elevation myocardial infarction. Capecitabine-induced cardiotoxicity may develop in patients who have had a previous episode of 5-FU-induced cardiotoxicity. Capecitabine-induced cardiotoxicity is a rare condition that may lead to diagnostic and therapeutic dilemmas.
dc.identifier.citationŞentürk, T. vd. (2009). "Capecitabine-induced cardiotoxicity mimicking myocardial infarction". Netherlands Heart Journal, 17(7-8), 277-280.
dc.identifier.endpage280
dc.identifier.issn1568-5888
dc.identifier.issue7-8
dc.identifier.pubmed19789694
dc.identifier.scopus2-s2.0-70349283313
dc.identifier.startpage277
dc.identifier.urihttps://doi.org/10.1007/BF03086265
dc.identifier.urihttps://link.springer.com/article/10.1007%2FBF03086265
dc.identifier.urihttp://hdl.handle.net/11452/23117
dc.identifier.volume17
dc.identifier.wos000269178900004
dc.indexed.wosSCIE
dc.language.isoen
dc.publisherBohn Stafleu van Loghum
dc.relation.journalNetherlands Heart Journal
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectCapecitabine
dc.subjectCardiotoxicity
dc.subjectMyocardial infarction
dc.subjectCardiovascular system & cardiology
dc.subject.emtreeCapecitabine
dc.subject.emtreeDiltiazem
dc.subject.emtreeFluorouracil
dc.subject.emtreeFolinic acid
dc.subject.emtreeIsosorbide mononitrate
dc.subject.emtreeOxaliplatin
dc.subject.emtreeAdult
dc.subject.emtreeArticle
dc.subject.emtreeCancer adjuvant therapy
dc.subject.emtreeCardiotoxicity
dc.subject.emtreeCase report
dc.subject.emtreeClinical feature
dc.subject.emtreeContinuous infusion
dc.subject.emtreeDifferential diagnosis
dc.subject.emtreeDrug effect
dc.subject.emtreeHeart infarction
dc.subject.emtreeHuman
dc.subject.emtreeMale
dc.subject.emtreeRectum carcinoma
dc.subject.emtreeST segment elevation
dc.subject.emtreeSymptom
dc.subject.emtreeThorax pain
dc.subject.scopusCapecitabine; Cardiotoxicity; Coronary Artery Spasm
dc.subject.wosCardiac & cardiovascular systems
dc.titleCapecitabine-induced cardiotoxicity mimicking myocardial infarction
dc.typeArticle
dc.wos.quartileQ3
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/Kardiyoloji Ana Bilim Dalı
local.contributor.departmentTıp Fakültesi/Tıbbi Onkoloji Ana Bilim Dalı
local.indexed.atScopus
local.indexed.atWOS

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Şentürk_vd_2009.pdf
Size:
330.93 KB
Format:
Adobe Portable Document Format
Description:

License bundle

Now showing 1 - 1 of 1
Placeholder
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: